Scholarlink

Background <p>Carbapenem-non-susceptible <i>Pseudomonas aeruginosa</i> (CnSPA) bloodstream infections (BSIs) are associated with high mortality and limited treatment options, yet long-term genomic–clinical data from China are scarce.</p> Methods <p>We retrospectively analyzed 52 non-duplicate CnSPA isolates causing BSIs from 2014 to 2023 in a tertiary hospital in eastern China. Whole-genome sequencing was used to characterize antimicrobial resistance genes (ARGs), carbapenem resistance–associated mutations, mobile genetic elements, sequence types (STs), serotypes, genetic relationship, and integron structures. Clinical data were integrated to identify risk factors for mortality and polymicrobial BSIs.</p> Results <p>CnSPA isolates showed high resistance to imipenem (98.1%) and multiple β-lactams and fluoroquinolones, while remaining susceptible to colistin. Carbapenemase genes were rare, whereas diverse ARGs, frequent <i>oprD</i> and <i>ampC</i> mutations, and widespread co-localization of ARGs with insertion sequences supported a major role for non-carbapenemase mechanisms and mobile genetic elements in resistance dissemination. Thirty-six distinct STs—including high-risk clones ST235, ST244, ST274, and ST357, heterogeneous serotypes and phylogenetic tree indicated substantial genomic diversity. Integron analysis revealed structurally diverse complete integrons, CALINs, and In0 elements in a subset of genomes. Clinically, mortality was 38.5%; prior carbapenem exposure, organ failure, and prolonged mechanical ventilation were independent predictors of death, while long-term catheterization was associated with polymicrobial BSIs.</p> Conclusions <p>CnSPA BSIs in this setting are driven by multifactorial resistance mechanisms, high-risk clones, and mobile genetic elements, with modifiable clinical factors strongly linked to poor outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic characteristics and risk factor analysis of carbapenem-non-susceptible Pseudomonas aeruginosa causing bacteremia in a tertiary hospital (2014–2023)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月2日

查看全文
  • Junbin Zhai,
  • Xiaoli Cao,
  • Chang Liu,
  • Jie Zheng,
  • Yan Zhang,
  • Shuo Gao,
  • Xuejing Xu

摘要

Background

Carbapenem-non-susceptible Pseudomonas aeruginosa (CnSPA) bloodstream infections (BSIs) are associated with high mortality and limited treatment options, yet long-term genomic–clinical data from China are scarce.

Methods

We retrospectively analyzed 52 non-duplicate CnSPA isolates causing BSIs from 2014 to 2023 in a tertiary hospital in eastern China. Whole-genome sequencing was used to characterize antimicrobial resistance genes (ARGs), carbapenem resistance–associated mutations, mobile genetic elements, sequence types (STs), serotypes, genetic relationship, and integron structures. Clinical data were integrated to identify risk factors for mortality and polymicrobial BSIs.

Results

CnSPA isolates showed high resistance to imipenem (98.1%) and multiple β-lactams and fluoroquinolones, while remaining susceptible to colistin. Carbapenemase genes were rare, whereas diverse ARGs, frequent oprD and ampC mutations, and widespread co-localization of ARGs with insertion sequences supported a major role for non-carbapenemase mechanisms and mobile genetic elements in resistance dissemination. Thirty-six distinct STs—including high-risk clones ST235, ST244, ST274, and ST357, heterogeneous serotypes and phylogenetic tree indicated substantial genomic diversity. Integron analysis revealed structurally diverse complete integrons, CALINs, and In0 elements in a subset of genomes. Clinically, mortality was 38.5%; prior carbapenem exposure, organ failure, and prolonged mechanical ventilation were independent predictors of death, while long-term catheterization was associated with polymicrobial BSIs.

Conclusions

CnSPA BSIs in this setting are driven by multifactorial resistance mechanisms, high-risk clones, and mobile genetic elements, with modifiable clinical factors strongly linked to poor outcomes.